Spi Pharma (United States) holds 3 active US FDA Type II Drug Master Files and 9 inactive, has DMF or CEP filings on record for 2 active ingredients, holds 6 active Type IV (excipient) Drug Master Files and is linked to 3 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Spi Pharma: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/spi-pharma

Overview

Spi Pharma is a pharmaceutical company headquartered in Wilmington, United States.

Active ingredients with DMF or CEP filings

Substances for which Spi Pharma holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Spi Pharma holds 3 active (12 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CALCIUM CARBONATE, MAG. HYDROXIDE GRANActive2024-06-14
  • MAGNESIUM HYDROXIDE USP BARCROFT™ 5100 CG POWDERActive2024-03-06
  • CALCIUM CARBONATE DC TYPE CS90 PRODUCTSActive2008-02-27
  • ACTIMASK® IBUPROFEN 92SInactive2017-04-13
  • BARCROFT™ 5100 CG MAGNESIUM HYDROXIDE POWDER USPInactive2015-06-23
  • BULK ACTIMASK TASTE MASKED ACETAMINOPHENInactive2011-08-05
  • MAGNESIUM HYDROXIDE DC MS90 PRODUCTSInactive2009-02-06
  • BARCROFT(TM) 5300D MAGNESIUM HYDROXIDE USPInactive2006-04-07
  • MAGNESIUM HYDROXIDE PASTE/POWDER USPInactive2001-03-19
  • DRIED ALUMINUM HYDROXIDE GEL, USPInactive1998-10-01
  • CALCIUM CARBONATE/STARCH GRANULATIONInactive1992-04-24
  • MANNOGEM® MANNITOL USP PRODUCTSInactive1964-05-13

Excipient Drug Master Files

Spi Pharma holds 6 active (10 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • ULTRABURSTActive2022-08-17
  • PHARMABURST® 530Active2014-06-18
  • PHARMABURST® 500 AND SL SERIESActive2010-08-27
  • SODIUM BICARBONATE PRODUCTSActive2007-03-30
  • PHARMABURST(TM) C1Active2003-12-22
  • PHARMABURST® B SERIES PRODUCTSActive2002-07-03
  • ADVANTOL 300Inactive2009-09-11
  • PHARMAGUM(TM) CInactive2006-04-10
  • MANNOGEM(TM) EZ SPRAY DRIED MANNITOL USPInactive2003-01-16
  • SORBITOL SPECIAL (PLASTICIZER)Inactive1996-01-03

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Spi Pharma, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Spi Pharma in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Spi Pharma?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.